Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 270,106 | 103,039 | 47,572 |
| General And Administrative Expense | 241,660 | 87,089 | 39,522 |
| Other Operating Expenses | 4,443 | 5,091 | 12,473 |
| Operating Expense | 274,549 | 108,130 | 60,045 |
| Operating Income | -274,549 | -108,130 | -60,045 |
| EBIT | -274,549 | -108,130 | -60,045 |
| Interest Income | 825.00 | 916.00 | 643.00 |
| Interest Income Non Operating | 825.00 | 916.00 | 643.00 |
| Net Interest Income | 825.00 | 916.00 | 643.00 |
| Other Income Expense | -- | 17,436 | 450.00 |
| Gain On Sale Of Security | -- | 17,436 | 450.00 |
| Pretax Income | -273,724 | -89,778 | -58,952 |
| Tax Provision | 0.00 | 7,236 | 0.00 |
| Tax Effect Of Unusual Items | 0.00 | 2,615 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -273,724 | -97,014 | -58,952 |
| Net Income From Continuing Operation Net Minority Interest | -273,724 | -97,014 | -58,952 |
| Net Income Including Noncontrolling Interests | -273,724 | -97,014 | -58,952 |
| Net Income Common Stockholders | -273,724 | -97,014 | -58,952 |
| Net Income | -273,724 | -97,014 | -58,952 |
| EBITDA | -274,549 | -108,130 | -60,045 |
| Normalized EBITDA | -274,549 | -125,566 | -60,495 |
| Basic EPS | -0.01 | -- | -0.00 |
| Diluted EPS | -0.01 | -- | -0.00 |
| Basic Average Shares | 41.4M | -- | 41.4M |
| Diluted Average Shares | 41.4M | -- | 41.4M |
| Total Unusual Items | -- | 17,436 | 450.00 |
| Total Unusual Items Excluding Goodwill | -- | 17,436 | 450.00 |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.00 |
| Normalized Income | -273,724 | -111,835 | -59,402 |
| Diluted NI Availto Com Stockholders | -273,724 | -97,014 | -58,952 |
| Net Income Continuous Operations | -273,724 | -97,014 | -58,952 |
| Net Non Operating Interest Income Expense | 825.00 | 916.00 | 643.00 |
| Other Gand A | 171,515 | 92,464 | 14,847 |
| Salaries And Wages | 70,145 | -5,375 | 24,675 |
| Selling And Marketing Expense | 28,446 | 15,950 | 8,050 |
| Total Expenses | 274,549 | 108,130 | 60,045 |
| Line Item | Q3 2025Sep 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|
| Cash And Cash Equivalents | 96,842 | -- | -- |
| Cash Cash Equivalents And Short Term Investments | 96,842 | -- | -- |
| Cash Financial | 96,842 | -- | -- |
| Receivables | 11,942 | -- | -- |
| Current Assets | 108,784 | -- | -- |
| Net PPE | 1.1M | -- | -- |
| Total Non Current Assets | 1.1M | -- | -- |
| Total Assets | 1.3M | -- | -- |
| Current Debt | 27,935 | -- | -- |
| Current Debt And Capital Lease Obligation | 27,935 | -- | -- |
| Accounts Payable | 122,283 | -- | -- |
| Payables | 122,283 | -- | -- |
| Payables And Accrued Expenses | 122,283 | -- | -- |
| Current Liabilities | 150,218 | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- | -- |
| Total Liabilities Net Minority Interest | 150,218 | -- | -- |
| Common Stock | 1.6M | -- | -- |
| Capital Stock | 1.6M | -- | -- |
| Retained Earnings | -501,865 | -- | -- |
| Gains Losses Not Affecting Retained Earnings | -28,454 | -- | -- |
| Common Stock Equity | 1.1M | -- | -- |
| Stockholders Equity | 1.1M | -- | -- |
| Total Equity Gross Minority Interest | 1.1M | -- | -- |
| Total Capitalization | 1.1M | -- | -- |
| Net Tangible Assets | 1.1M | -- | -- |
| Tangible Book Value | 1.1M | -- | -- |
| Working Capital | -41,434 | -- | -- |
| Invested Capital | 1.1M | -- | -- |
| Total Debt | 27,935 | -- | -- |
| Share Issued | 41.4M | -- | -- |
| Ordinary Shares Number | 41.4M | -- | -- |
| Foreign Currency Translation Adjustments | -28,454 | -- | -- |
| Other Current Borrowings | 27,935 | -- | -- |
| Taxes Receivable | 11,942 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|
| Operating Cash Flow | -- | 120,049 | -172,254 |
| Cash Flow From Continuing Operating Activities | -- | 120,049 | -172,254 |
| Stock Based Compensation | -- | 19,300 | 0.00 |
| Change In Working Capital | -- | 81,261 | 3,200 |
| Change In Receivables | -- | -12,649 | 0.00 |
| Change In Payables And Accrued Expense | -- | 93,910 | 3,200 |
| Capital Expenditure | -- | -292,310 | -258,577 |
| Purchase Of PPE | -- | -292,310 | -258,577 |
| Net PPE Purchase And Sale | -- | -292,310 | -258,577 |
| Investing Cash Flow | -- | -292,310 | -258,577 |
| Cash Flow From Continuing Investing Activities | -- | -292,310 | -258,577 |
| Issuance Of Debt | -- | -167,715 | 232,313 |
| Net Issuance Payments Of Debt | -- | -167,715 | 232,313 |
| Issuance Of Capital Stock | -- | 304,912 | 215,715 |
| Net Common Stock Issuance | -- | 304,912 | 215,715 |
| Financing Cash Flow | -- | 137,197 | 448,028 |
| Cash Flow From Continuing Financing Activities | -- | 137,197 | 448,028 |
| Effect Of Exchange Rate Changes | -- | 24,286 | -6,400 |
| Changes In Cash | -- | -35,064 | 17,197 |
| Beginning Cash Position | -- | 10,797 | 0.00 |
| End Cash Position | -- | 19.00 | 10,797 |
| Free Cash Flow | -- | -172,261 | -430,831 |
| Income Tax Paid Supplemental Data | -- | -20.00 | 20.00 |
| Interest Paid Supplemental Data | -- | 0.00 | 0.00 |
| Common Stock Issuance | -- | 304,912 | 215,715 |
| Net Income From Continuing Operations | -- | 19,488 | -175,454 |
| Net Short Term Debt Issuance | -- | -167,715 | 232,313 |
| Short Term Debt Issuance | -- | -167,715 | 232,313 |